User profiles for Tagreed A. Mazi
 | Tagreed A. MaziUniversity of California- Davis Verified email at ucdavis.edu Cited by 112 |
[HTML][HTML] Erythritol: an in-depth discussion of its potential to be a beneficial dietary component
TA Mazi, KL Stanhope - Nutrients, 2023 - mdpi.com
The sugar alcohol erythritol is a relatively new food ingredient. It is naturally occurring in
plants, however, produced commercially by fermentation. It is also produced endogenously via …
plants, however, produced commercially by fermentation. It is also produced endogenously via …
[HTML][HTML] Lipid and energy metabolism in Wilson disease
Copper accumulation and deficiency are reciprocally connected to lipid metabolism. In Wilson
disease (WD), which is caused by a genetic loss of function of the copper-transporting P-…
disease (WD), which is caused by a genetic loss of function of the copper-transporting P-…
[HTML][HTML] Elevated Erythritol: A Marker of Metabolic Dysregulation or Contributor to the Pathogenesis of Cardiometabolic Disease?
TA Mazi, KL Stanhope - Nutrients, 2023 - mdpi.com
Erythritol is a non-nutritive sugar replacement that can be endogenously produced by
humans. Witkowski et al. reported that elevated circulating erythritol is associated with adverse …
humans. Witkowski et al. reported that elevated circulating erythritol is associated with adverse …
[HTML][HTML] Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study
(221 words) Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes
steatosis (NAFL) and nonalcoholic steatohepatitis (NASH). In the US, Hispanics (HIS) are …
steatosis (NAFL) and nonalcoholic steatohepatitis (NASH). In the US, Hispanics (HIS) are …
[HTML][HTML] Dysregulated choline, methionine, and aromatic amino acid metabolism in patients with Wilson disease: exploratory metabolomic profiling and implications for …
Wilson disease (WD) is a genetic copper overload condition characterized by hepatic and
neuropsychiatric symptoms with a not well-understood pathogenesis. Dysregulated …
neuropsychiatric symptoms with a not well-understood pathogenesis. Dysregulated …
[HTML][HTML] The role of the intestine in metabolic dysregulation in murine Wilson disease
Background: The clinical manifestations of Wilson disease (WD) are related to copper
accumulation in the liver and the brain, but little is known about other tissue involvement regarding …
accumulation in the liver and the brain, but little is known about other tissue involvement regarding …
[HTML][HTML] Wilson disease: intersecting DNA methylation and histone acetylation regulation of gene expression in a mouse model of hepatic copper accumulation
…, DA Goncharov, EA Goncharova, TA Mazi… - Cellular and molecular …, 2021 - Elsevier
Background & Aims The pathogenesis of Wilson disease (WD) involves hepatic and brain
copper accumulation resulting from pathogenic variants affecting the ATP7B gene and …
copper accumulation resulting from pathogenic variants affecting the ATP7B gene and …
mtDNA depletion‐like syndrome in Wilson disease
…, CE Mordaunt, DA Kieffer, TA Mazi… - Liver …, 2020 - Wiley Online Library
Background and Aims Wilson disease (WD) is caused by mutations in the copper transporter
ATP7B, with its main pathology attributed to copper‐mediated oxidative damage. The …
ATP7B, with its main pathology attributed to copper‐mediated oxidative damage. The …
[HTML][HTML] Hepatic oxylipin profiles in mouse models of Wilson disease: New insights into early hepatic manifestations
Hepatic inflammation is commonly identified in Wilson disease (WD), a genetic disease of
hepatic and brain copper accumulation. Copper accumulation is associated with increased …
hepatic and brain copper accumulation. Copper accumulation is associated with increased …
[HTML][HTML] Plasma oxylipin profile discriminates ethnicities in subjects with non-alcoholic steatohepatitis: an exploratory analysis
Non-alcoholic fatty liver disease (NAFLD) is a common liver pathology that includes steatosis,
or non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH). Without a …
or non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH). Without a …